Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Bionor Holding AS
AS
Bankrupt
Org 919282134
Gaustadalléen 21, 0349
Oslo
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2017 · 9 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Bionor Holding AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (1)
AA
Aslak Aslaksen
Contact Person
Contact Person
2017 – 2026
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
BS
Birger Sørensen
Chairman
Chairman
2017
Former (3)
DA
Dag Arne Wivelstad
Board of Directors
Board of Directors
2017 – 2024
KT
Knut Terje Smerud
Board of Directors
Board of Directors
2017 – 2024
AA
Aslak Aslaksen
Board of Directors
Board of Directors
2017 – 2024
Shareholders
As of last annual report
IMMUNOR AS — 35.87%
Jakob Hatteland Holding As — 14.11%
Wivel Invest As — 12%
A A Holding As — 10.02%
Svenska Handelsbanken Ab — 6.83%
Apex Capital As — 3.44%
Smerud Medical Research International As — 2.8%
Solon Eiendom As — 2.24%
Chrishøeg As — 1.7%
Malise As — 1.7%
Grafo As — 1.5%
Jan Inge Sageie As — 1.1%
Ken Sakai — 1.1%
94%
Shareholder
Type
Ownership
Votes
Since
IMMUNOR AS
Company
35.87%
35.87%
2025
Jakob Hatteland Holding As
Company
14.11%
14.11%
2025
Wivel Invest As
Company
12%
12%
2025
A A Holding As
Company
10.02%
10.02%
2025
Svenska Handelsbanken Ab
Company
6.83%
6.83%
2025
Apex Capital As
Company
3.44%
3.44%
2025
Smerud Medical Research International As
Company
2.8%
2.8%
2025
Solon Eiendom As
Company
2.24%
2.24%
2025
Chrishøeg As
Company
1.7%
1.7%
2025
Malise As
Company
1.7%
1.7%
2025
Grafo As
Company
1.5%
1.5%
2025
Jan Inge Sageie As
Company
1.1%
1.1%
2025
Ken Sakai
Individual
1.1%
1.1%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Bionor Holding AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network